Table 3. Diagnosis and Site of... | American Society of Hematology

Table 3.

Diagnosis and Site of Progression

Diagnosis	No. of Patients	Patients Suffering From Progres- sion	Site of Progression (any involvement)^3-150
Diagnosis	No. of Patients	Patients Suffering From Progres- sion	Local	BM	CNS	Testes	New Site
Burkitt type	266	17	12	3	1	1	1
B-ALL	56	6	3	2	1	0	1
Diffuse large B-cell lymphoma
Centroblastic	42	2	2
Immunoblastic	6	0
Mediastinal (thymic) B-cell lymphoma	8	1	1
NHL, not further classified:
B-cell	30	1	1
Immunophenotype NA^3-151	5

Total	413	27

Diagnosis	No. of Patients	Patients Suffering From Progres- sion	Site of Progression (any involvement)^3-150
Diagnosis	No. of Patients	Patients Suffering From Progres- sion	Local	BM	CNS	Testes	New Site
Burkitt type	266	17	12	3	1	1	1
B-ALL	56	6	3	2	1	0	1
Diffuse large B-cell lymphoma
Centroblastic	42	2	2
Immunoblastic	6	0
Mediastinal (thymic) B-cell lymphoma	8	1	1
NHL, not further classified:
B-cell	30	1	1
Immunophenotype NA^3-151	5

Total	413	27

Multiple sites can be involved in 1 patient.

Abdominal primary and lymphoid origin confirmed by CD45 positivity, cytokeratin negativity.